Nelfinavir and Lenalidomide/Dexamethasone in Progressive Multiple Myeloma
Clinical trial NCT01555281 · TERMINATED
Trial details
- NCT number
- NCT01555281
- Sponsor
- Swiss Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-23
- Primary completion
- 2022-06-08
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.